91775-62-1

Basic information

• Product Name: 3-BROMO-8-METHOXYIMIDAZO[1,2-A]PYRAZINE
• Synonyms: 3-BROMO-8-METHOXYIMIDAZO[1,2-A]PYRAZINE
• CAS NO: 91775-62-1
• Molecular Formula: C₇H₆BrN₃O
• Molecular Weight: 228.05
• Mol File: 91775-62-1.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Density: 1.8g/cm³
• Refractive Index: 1.692
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 3-BROMO-8-METHOXYIMIDAZO[1,2-A]PYRAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BROMO-8-METHOXYIMIDAZO[1,2-A]PYRAZINE(91775-62-1)
• EPA Substance Registry System: 3-BROMO-8-METHOXYIMIDAZO[1,2-A]PYRAZINE(91775-62-1)

Safety Data

• Hazardous Substances Data: 91775-62-1(Hazardous Substances Data)

Usage

General Description

3-BROMO-8-METHOXYIMIDAZO[1,2-A]PYRAZINE is a chemical compound with the molecular formula C6H5BrN4O. It is a heterocyclic aromatic compound that contains a bromine atom and a methoxy group attached to an imidazo[1,2-a]pyrazine ring system. 3-BROMO-8-METHOXYIMIDAZO[1,2-A]PYRAZINE has been studied for its potential applications in the pharmaceutical and agrochemical industries due to its unique structure and properties. It may be used in the synthesis of other organic compounds and may have biological activities that could be useful in drug discovery and development. Additional research is needed to fully understand the potential uses and effects of 3-BROMO-8-METHOXYIMIDAZO[1,2-A]PYRAZINE.

InChI:InChI=1/C7H6BrN3O/c1-12-7-6-10-4-5(8)11(6)3-2-9-7/h2-4H,1H3

Upstream product

• 143591-61-1 3-bromo-8-chloro-imidazo[1,2-a]pyrazine 
• 124-41-4 sodium methylate 
• 69214-33-1 8-chloroimidazo[1,2-α]pyrazine 

Downstream Products

• 689297-65-2 2'-fluoro-5'-(8-oxo-7,8-dihydroimidazo[1,2-a]pyrazin-3-yl)-biphenyl-2-carbonitrile 
• 689297-67-4 3-bromo-7H-imidazo[1,2-a]pyrazin-8-one 
• 689297-63-0 2'-fluoro-5'-(8-methoxyimidazo[1,2-a]pyrazin-3-yl)-biphenyl-2-carbonitrile 

Relevant articles and documents

MIDAZOPYRAZINONES AND IMIDAZOTRIAZINONES DERIVATES AS GABA-A RECEPTOR ANXIOLYTIC

The present invention discloses a compound of formula I, or a pharmaceutically acceptable salt thereof: (I) wherein -U-V- represents -CH=CH-, or -CH2-CH2-, -N=CH- or -CH=N-; X1 represents hydrogen, halogen, C1-6 alkyl, trifluoromethyl or C1-6 alkoxy; X2 represents hydrogen or halogen; Y represents a chemical bond, an oxygen atom, or a -NH- or -OCH2- linkage; Z represents an optionally substituted aryl or heteroaryl group; R1 represents hydrocarbon, a heterocyclic group, trifluoromethyl, -SO2Ra, -SO2NRaRb, -CORa, -CO2Ra or -CONRaRb; and Ra and Rb independently represent hydrogen, hydrocarbon or a heterocyclic group;pharmaceutical compositions comprising it; its use in methods of treatment; use of it in the manufacture of a medicament for treating and/or preventing anxiety; convulsions or a cognitive disorder; and methods of treatment using it.